DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @AmericanBanking | 9 |
| @TickerReport | 6 |
| @ZolmaxNews | 6 |
| @dakotafinancial | 5 |
| @ThisLincolnian | 5 |
Recent Tweets for ALKS
 |
@SwingTradeBot Recent $ALKS technical alerts: Narrow Range Bar plus 4 more alerts... https://t.co/LZXCqc9JTR April 4th 2020, 9:04am |
 |
@dailypoliticaln Alkermes Plc $ALKS CEO Richard F. Pops Sells 50,000 Shares https://t.co/1oGrmG2QF5 April 4th 2020, 7:04am |
 |
@TheMarketsDaily Alkermes Plc $ALKS CEO Richard F. Pops Sells 50,000 Shares https://t.co/JDN3wH3scm April 4th 2020, 7:04am |
 |
@EnterpriseLeade Alkermes Plc $ALKS CEO Richard F. Pops Sells 50,000 Shares https://t.co/9TJXEt65lB April 4th 2020, 7:04am |
 |
@AmericanBanking Alkermes Plc $ALKS Expected to Announce Quarterly Sales of $224.97 Million https://t.co/tk0jYTzm7x #stocks April 4th 2020, 4:04am |
 |
@ZolmaxNews Alkermes Plc $ALKS Expected to Announce Quarterly Sales of $224.97 Million https://t.co/8ADRYhJoJE April 4th 2020, 4:04am |
 |
@ThisLincolnian Alkermes Plc $ALKS Expected to Announce Quarterly Sales of $224.97 Million https://t.co/qZDKiyG02W April 4th 2020, 4:04am |
 |
@TickerReport Alkermes Plc $ALKS Expected to Announce Quarterly Sales of $224.97 Million https://t.co/CY27SCiHnJ April 4th 2020, 4:04am |
 |
@InsiderAlertsIA $ALKS: New Insider Filing on Alkermes plc.'s Director and CEO, Alkermes plc RICHARD F POPS: https://t.co/URrMl4Wt8S April 4th 2020, 2:04am |
 |
@HealthcareBeat Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $ALKS https://t.co/e1kYL4783V April 4th 2020, 12:04am |
 |
@insider_filings $ALKS: POPS RICHARD F sold $689,500 in Alkermes plc. https://t.co/UUtlO7eF57 April 4th 2020, 12:04am |
 |
@Stock_News_Now $ALKS: New SEC Filing for ALKS: Form DEFA14A (No. 0001564590-20-015306): https://t.co/62gpapT2FN April 3rd 2020, 5:04pm |
|
@AmericanBanking Alkermes Plc $ALKS CEO Richard F. Pops Sells 50,000 Shares https://t.co/hC3yZcEDOp #stocks April 3rd 2020, 5:04pm |
 |
@ExecPayOrg Alkermes CEO Richard Pops' 2019 pay slips 14% to $14.6M https://t.co/wic0No7Dar $ALKS #execpay April 3rd 2020, 5:04pm |
 |
@MonitorAction $ALKS Richard Pops Dumps 50K Shares of Alkermes plc. https://t.co/RAnuvA4FG9 April 3rd 2020, 4:04pm |
 |
@StockTexts $ALKS Alkermes plc SEC Filing: Form 4 https://t.co/GaqS37cs6L April 3rd 2020, 4:04pm |
|
@HealthcareBeat Pearl River Capital Buys New Stake in Alkermes $ALKS https://t.co/17EFm48nlu April 3rd 2020, 9:04am |
 |
@stocknewstimes Alkermes $ALKS Price Target Cut to $16.00 https://t.co/BAJgu4I9tK April 2nd 2020, 11:04am |
|
@AmericanBanking Alkermes $ALKS PT Lowered to $16.00 at Morgan Stanley https://t.co/Knz3dRFX0W #stocks April 2nd 2020, 10:04am |
|
@ZolmaxNews Zacks: Analysts Expect Alkermes Plc $ALKS to Post -$0.09 EPS https://t.co/eGUwjyJcOn April 2nd 2020, 5:04am |
|
@TickerReport Analysts Anticipate Alkermes Plc $ALKS Will Announce Earnings of -$0.09 Per Share https://t.co/jVEV3gwYgg April 2nd 2020, 5:04am |
|
@AmericanBanking Analysts Anticipate Alkermes Plc $ALKS Will Announce Earnings of -$0.09 Per Share https://t.co/83Zi7NtWPL #stocks April 2nd 2020, 5:04am |
|
@ZolmaxNews Alkermes Plc $ALKS Short Interest Up 12.7% in March https://t.co/ifkQA1wZFi April 1st 2020, 1:04am |
|
@dakotafinancial Alkermes Plc $ALKS Short Interest Up 12.7% in March https://t.co/giL1VhF3YM April 1st 2020, 1:04am |
 |
@WatchlistN Alkermes Plc $ALKS Short Interest Up 12.7% in March https://t.co/9fFuSiCahX April 1st 2020, 1:04am |
 |
@TickerSentiment Sentiment for $ALKS out of 2 total scores; 100 % is positive and 0 % is negative. #sentiment https://t.co/eXgJ8JhpPy March 31st 2020, 9:03am |
|
@ThisLincolnian Alkermes Plc $ALKS Sees Large Growth in Short Interest https://t.co/KPLOrSZ99B March 31st 2020, 1:03am |
|
@InsiderAlertsIA $ALKS: New Insider Filing on Alkermes plc.'s Director and CEO, Alkermes plc RICHARD F POPS: https://t.co/ASrtXLJZSN March 30th 2020, 12:03pm |
 |
@Gambiste1 RT @avidresearch: @stevedoc22 $ALKS did the run-in period with control arm (think pbo in their case) and its a way to reduce impact of plac… March 30th 2020, 11:03am |
 |
@avidresearch @stevedoc22 $ALKS did the run-in period with control arm (think pbo in their case) and its a way to reduce impact o… https://t.co/7nts8pJq2J March 30th 2020, 9:03am |
|
@AmericanBanking Alkermes Plc $ALKS Short Interest Update https://t.co/cZErNVVOJh #stocks March 30th 2020, 8:03am |
|
@InsiderAlertsIA $ALKS: New Insider Filing on Alkermes plc.'s SVP, Corp Dev., Alkermes, Inc. MICHAEL J LANDINE: https://t.co/yw4A4S76zO March 30th 2020, 8:03am |
|
@dailypoliticaln Short Interest in Alkermes Plc $ALKS Expands By 12.7% https://t.co/HkiKCZFJE8 March 30th 2020, 8:03am |
|
@HealthcareBeat Alkermes SVP Michael J. Landine Sells 25,000 Shares $ALKS https://t.co/NybAQNZG3O March 29th 2020, 9:03pm |
|
@HealthcareBeat Head-To-Head Comparison: Onconova Therapeutics vs. Alkermes $ONTX $ALKS https://t.co/YULsKVEAqF March 29th 2020, 7:03am |
|
@stocknewstimes Head-To-Head Comparison: Onconova Therapeutics $ONTX vs. Alkermes $ALKS https://t.co/ET5GgMPwPY March 29th 2020, 7:03am |
 |
@ConsumerFeed Head-To-Head Comparison: Onconova Therapeutics $ONTX vs. Alkermes $ALKS https://t.co/Jeh1pNNvlX March 29th 2020, 6:03am |
|
@EnterpriseLeade Alkermes Plc $ALKS SVP Sells $347,750.00 in Stock https://t.co/IWv65qXLgz March 29th 2020, 5:03am |
|
@ZolmaxNews Alkermes Plc $ALKS SVP Sells $347,750.00 in Stock https://t.co/V9ZXHuDlY5 March 29th 2020, 5:03am |
|
@WatchlistN Alkermes Plc $ALKS SVP Sells $347,750.00 in Stock https://t.co/MRCMckQCOm March 29th 2020, 5:03am |
|
@ThisLincolnian Alkermes Plc $ALKS SVP Sells $347,750.00 in Stock https://t.co/pGgyl6Rx3B March 29th 2020, 5:03am |
|
@dakotafinancial Alkermes Plc $ALKS CEO Sells $1,077,000.00 in Stock https://t.co/rMcsFxVp9q March 29th 2020, 4:03am |
|
@WatchlistN Alkermes Plc $ALKS CEO Sells $1,077,000.00 in Stock https://t.co/Q48MIXjGLU March 29th 2020, 4:03am |
|
@ThisLincolnian Michael J. Landine Sells 25,000 Shares of Alkermes Plc $ALKS Stock https://t.co/dRZUjbEzrQ March 28th 2020, 5:03am |
|
@TickerReport Michael J. Landine Sells 25,000 Shares of Alkermes Plc $ALKS Stock https://t.co/joSSyPvBDo March 28th 2020, 5:03am |
|
@ThisLincolnian Richard F. Pops Sells 75,000 Shares of Alkermes Plc $ALKS Stock https://t.co/2vHg5Dl4MV March 28th 2020, 4:03am |
|
@TickerReport Alkermes Plc $ALKS CEO Richard F. Pops Sells 75,000 Shares https://t.co/IsJrOtRN62 March 28th 2020, 4:03am |
 |
@BlueBioNow $ALKS considerable price movement -2.29 % change recently https://t.co/pOSy7CeMJf March 27th 2020, 12:03pm |
|
@dakotafinancial Alkermes Plc $ALKS SVP Michael J. Landine Sells 25,000 Shares https://t.co/UfojoDTGSK March 27th 2020, 10:03am |
|
@ConsumerFeed Alkermes Plc $ALKS SVP Sells $347,750.00 in Stock https://t.co/z88NPnP6Mq March 27th 2020, 10:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.